Direct Acting Oral Anticoagulants
Showing 1 - 25 of >10,000
Urin-based Point-of-Care Testing for Direct Oral Anticoagulants
Recruiting
- Stroke
- Urin-based test by the DOASENSE Dipstick Device
-
Gießen, Hesse, GermanyDepartment of Neurology, University Hospital Giessen
Sep 13, 2023
Anticoagulants; Increased Trial (catheter induced thromboprophylaxis)
Not yet recruiting
- Anticoagulants; Increased
- catheter induced thromboprophylaxis
- (no location specified)
Jan 21, 2023
Atrial Fibrillation, Thromboembolism, Venous Trial in Roma (DOACs)
Recruiting
- Atrial Fibrillation
- Thromboembolism, Venous
-
Roma, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Feb 20, 2023
Cryptogenic Ischemic Stroke, Patent Foramen Ovale Trial in France (Transcatheter PFO closure, Oral Anticoagulant, Direct-Acting,
Not yet recruiting
- Cryptogenic Ischemic Stroke
- Patent Foramen Ovale
- Transcatheter PFO closure
- +2 more
-
Amiens, France
- +30 more
May 20, 2022
Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)
Recruiting
- Ischemic Stroke
- Anticoagulant Adverse Reaction
- Dabigatran, rivaroxaban, apixaban, edoxaban
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 22, 2023
Direct Oral AntiCoagulants and Ticagrelor Study II
Not yet recruiting
- Novel Oral Anticoagulants
- +11 more
- Detection of genotype and RNA profile in platelet and white blood cell
- +2 more
-
Hefei, Anhui, China
- +5 more
Mar 1, 2023
Subdural Hematoma, Atrial Fibrillation Trial in Toronto (Direct Acting Oral Anticoagulant starting at Day 30, Direct Acting Oral
Not yet recruiting
- Subdural Hematoma
- Atrial Fibrillation
- Direct Acting Oral Anticoagulant starting at Day 30
- Direct Acting Oral Anticoagulant starting at Day 90
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Jul 26, 2022
Exploratory Drug Interaction Study Between SMIs and DOACs
Recruiting
- Solid Tumor
- Cancer, Lung
-
Nijmegen, Gelderland, Netherlands
- +1 more
Feb 7, 2023
Atrial Fibrillation, Recurrent Venous Thromboembolism Trial in Barcelona (dabigatran, rivaroxaban, apixaban or edoxaban)
Recruiting
- Atrial Fibrillation
- Recurrent Venous Thromboembolism
- dabigatran, rivaroxaban, apixaban or edoxaban
-
Barcelona, Catalonia, SpainHospital de la Santa Creu i Sant Pau
Apr 27, 2022
Coronary Artery Disease, Bleeding, Direct Acting Anticoagulant Adverse Reaction Trial in Italy, Spain (Direct-acting oral
Recruiting
- Coronary Artery Disease
- +2 more
- Direct-acting oral anticoagulation
-
Rozzano, Milan, Italy
- +3 more
Mar 22, 2022
Thrombus of Left Ventricle Trial in Bern
Recruiting
- Thrombus of Left Ventricle
-
Bern, SwitzerlandDepartment of Cardiology, University Hospital Bern
May 17, 2022
Oral Anticoagulant, Adherence Trial in Amiens (questionary)
Recruiting
- Oral Anticoagulant
- Adherence
- questionary
-
Amiens, FranceCHU Amiens
Jul 27, 2022
Direct Oral Anticoagulants for Treatment of Cerebral Venous
Recruiting
- Cerebral Venous Thrombosis
- Oral anticoagulant
-
Amsterdam, Noord-Holland, NetherlandsJonathan Coutinho
Feb 11, 2022
Heavy Menstrual Bleeding Trial in Frankfurt am Main (Apixaban 5 MG, Rivaroxaban 20 MG, Edoxaban 60 MG)
Recruiting
- Heavy Menstrual Bleeding
- Apixaban 5 MG
- +3 more
-
Frankfurt am Main, GermanyCardioangiology Center Bethanien (CCB)
Dec 29, 2021
Atrial Fibrillation Trial in Pessac (Specialized nurse consultation)
Active, not recruiting
- Atrial Fibrillation
- Specialized nurse consultation
-
Pessac, FranceCHU de Bordeaux
Feb 9, 2022
Real Life of New Oral Anticoagulants and Vitamin K Antagonists
Completed
- Atrial Fibrillation
- Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban
- Vitamin K antagonist: warfarin, fluindione, acenocoumarol
-
Paris, FranceAssistance Publique Hôpitaux de Paris
Mar 28, 2022
Direct Oral Anticoagulants (DOACs) in Hypercoagulable States
Completed
- Hypercoagulable States
- Observational
-
Dallas, TexasMethodist Dallas Medical Center
Dec 9, 2021
Direct Oral Anticoagulants for the Treatment of Mural Thrombus
Completed
- Acute Myocardial Infarction
-
Dallas, TexasMethodist Dallas Medical Center
Dec 9, 2021
Mild Head Injury, Antiplatelets, and Anticoagulants
Completed
- Craniocerebral Trauma
- Cerebral Hemorrhage
- direct anticoagulant
- +2 more
-
Roma, Rm, ItalyFondazione Policlinico Universitario Agostino Gemelli - IRCCS
Mar 29, 2022
Bleeding From Teeth, Bleeding Prophylaxis Trial in Worldwide (Tranexamic acid)
Recruiting
- Bleeding From Teeth
- Bleeding Prophylaxis
- Tranexamic acid
-
Loma Linda, California
- +18 more
Nov 21, 2023
Glomerular Filtration Rate-Estimating Equations During Use of
Terminated
- Atrial Fibrillation
- +2 more
- Blood sample
-
Montpellier, FranceUniversity Hospital
Oct 12, 2021
Point-of-Care Testing of Coagulation in Patients Treated With
Recruiting
- Anticoagulation With Direct Oral Anticoagulants
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Sep 2, 2021
Myocardial Infarction, Acute, Left Ventricular Thrombus Trial in Paris (Rivaroxaban 2.5 MG [Xarelto], DAPT strategy)
Recruiting
- Myocardial Infarction, Acute
- Left Ventricular Thrombus
- Rivaroxaban 2.5 MG [Xarelto]
- DAPT strategy
-
Paris, FranceHEGP
Oct 22, 2021
Atrial Fibrillation in Patients With Cancer (MAFIC Study)
Recruiting
- Cancer
- Atrial Fibrillation
- Low molecular weight heparin
-
Thessaloniki, Greece
- +1 more
Feb 14, 2022
Cancer Associated Thrombosis for Rivaroxaban - United States
Completed
- Treatment of Venous Thromboembolism in Cancer Patients
- Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Multiple Locations, ConnecticutMany Locations
May 18, 2022